Yumin Xu

759 total citations
41 papers, 516 citations indexed

About

Yumin Xu is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Yumin Xu has authored 41 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 14 papers in Hepatology and 13 papers in Molecular Biology. Recurrent topics in Yumin Xu's work include Liver Disease Diagnosis and Treatment (17 papers), Hepatitis B Virus Studies (12 papers) and Hepatitis C virus research (8 papers). Yumin Xu is often cited by papers focused on Liver Disease Diagnosis and Treatment (17 papers), Hepatitis B Virus Studies (12 papers) and Hepatitis C virus research (8 papers). Yumin Xu collaborates with scholars based in China, Australia and United States. Yumin Xu's co-authors include Xiaogang Xiang, Qing Xie, Zhujun Cao, Hui Wang, Shisan Bao, Gangde Zhao, Yuhan Liu, Wei Cai, Ziqiang Li and Kehui Liu and has published in prestigious journals such as PLoS ONE, Journal of Agricultural and Food Chemistry and The American Journal of Gastroenterology.

In The Last Decade

Yumin Xu

39 papers receiving 508 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yumin Xu China 14 266 203 183 119 51 41 516
Jin‐Zhong Dong China 8 130 0.5× 108 0.5× 152 0.8× 86 0.7× 50 1.0× 13 354
Sanae Hayashi Japan 13 231 0.9× 145 0.7× 155 0.8× 37 0.3× 53 1.0× 31 518
María Mora González López Ledesma Argentina 8 348 1.3× 116 0.6× 251 1.4× 273 2.3× 41 0.8× 15 596
Hongshan Wei China 15 289 1.1× 212 1.0× 160 0.9× 46 0.4× 55 1.1× 67 658
John T. Baber United States 5 158 0.6× 203 1.0× 104 0.6× 37 0.3× 128 2.5× 5 435
Hye–Jun Shin South Korea 9 227 0.9× 148 0.7× 179 1.0× 73 0.6× 20 0.4× 10 439
Reben Raeman United States 11 166 0.6× 90 0.4× 196 1.1× 41 0.3× 85 1.7× 18 425
Shanthi Wasser Singapore 9 266 1.0× 253 1.2× 291 1.6× 210 1.8× 26 0.5× 10 672
Huichun Xing China 13 257 1.0× 161 0.8× 163 0.9× 18 0.2× 53 1.0× 47 477
Lingling Jia China 13 182 0.7× 172 0.8× 95 0.5× 24 0.2× 66 1.3× 34 448

Countries citing papers authored by Yumin Xu

Since Specialization
Citations

This map shows the geographic impact of Yumin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yumin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yumin Xu more than expected).

Fields of papers citing papers by Yumin Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yumin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yumin Xu. The network helps show where Yumin Xu may publish in the future.

Co-authorship network of co-authors of Yumin Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Yumin Xu. A scholar is included among the top collaborators of Yumin Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yumin Xu. Yumin Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yichen, et al.. (2024). The Impact of Infection Control Policies on Hospital Acquired Infections by MDROs from 2016 to 2023. Infection and Drug Resistance. Volume 17. 4213–4221.
2.
Chen, Feng-Zhi, Shujun Peng, Fan Yang, et al.. (2024). Nitidine chloride inhibits mTORC1 signaling through ATF4-mediated Sestrin2 induction and targets IGF2R for lysosomal degradation. Life Sciences. 353. 122918–122918. 4 indexed citations
3.
Ma, Di, Gangde Zhao, Xiaolin Wang, et al.. (2023). The 20 years transition of clinical characteristics and metabolic risk factors in primary liver cancer patients from China. Frontiers in Oncology. 13. 1109980–1109980. 5 indexed citations
4.
Zhang, Yibo, Yichen Wang, Zi-Ke Sheng, et al.. (2023). Incidence Rate, Pathogens and Economic Burden of Catheter-Related Bloodstream Infection: A Single-Center, Retrospective Case-Control Study. Infection and Drug Resistance. Volume 16. 3551–3560. 13 indexed citations
5.
Liu, Yahui, Jing Cai, Junjie Li, et al.. (2023). Clinical characteristics of respiratory tract infection caused by Klebsiella pneumoniae in immunocompromised patients: a retrospective cohort study. Frontiers in Cellular and Infection Microbiology. 13. 1137664–1137664. 9 indexed citations
6.
Gao, Yulian, et al.. (2022). Prognostic Risk Factors of Carbapenem-Resistant Gram-Negative Bacteria Bloodstream Infection in Immunosuppressed Patients: A 7-Year Retrospective Cohort Study. Infection and Drug Resistance. Volume 15. 6451–6462. 4 indexed citations
7.
8.
Qu, Wei, Cong Liu, Yating Xu, Yumin Xu, & Mengcheng Luo. (2021). The formation and repair of DNA double-strand breaks in mammalian meiosis. Asian Journal of Andrology. 23(6). 572–579. 14 indexed citations
9.
Li, Jianbo, Panfeng Wu, Ziqi Yu, et al.. (2021). Chromatin-Associated Protein Sugp2 Involved in mRNA Alternative Splicing During Mouse Spermatogenesis. Frontiers in Veterinary Science. 8. 754021–754021. 2 indexed citations
10.
Zhao, Qingqing, Kehui Liu, Xiaojun Zhu, et al.. (2020). Anti-viral effect in chronic hepatitis B patients with normal or mildly elevated alanine aminotransferase. Antiviral Research. 184. 104953–104953. 8 indexed citations
11.
Cao, Zhujun, Yuhan Liu, Chuanwu Zhu, et al.. (2020). Bacterial infection triggers and complicates acute-on-chronic liver failure in patients with hepatitis B virus-decompensated cirrhosis: A retrospective cohort study. World Journal of Gastroenterology. 26(6). 645–656. 10 indexed citations
12.
Xu, Yumin, Zhujun Cao, Ziqiang Li, et al.. (2019). Long Non-coding RNA NEAT1 Alleviates Acute-on-Chronic Liver Failure Through Blocking TRAF6 Mediated Inflammatory Response. Frontiers in Physiology. 10. 1503–1503. 16 indexed citations
13.
Xu, Yumin, Yuhan Liu, Zhujun Cao, et al.. (2019). Comparison of FibroTouch and FibroScan for staging fibrosis in chronic liver disease: Single-center prospective study. Digestive and Liver Disease. 51(9). 1323–1329. 32 indexed citations
14.
Yan, Lei, Chuanwu Zhu, Jing Li, et al.. (2018). Entecavir add-on or switch-to pegylated interferon improves HBsAg clearance in HBe antigen negative chronic hepatitis B patients. Infection and Drug Resistance. Volume 11. 2001–2009. 12 indexed citations
15.
Wang, Hui, Haiqing Wu, Shisan Bao, et al.. (2015). Association of IPS1 polymorphisms with peginterferon efficacy in chronic hepatitis B with HBeAg-positive in the Chinese population. Infection Genetics and Evolution. 31. 161–168. 6 indexed citations
16.
Miao, Huilai, et al.. (2014). MiR-371-5p Facilitates Pancreatic Cancer Cell Proliferation and Decreases Patient Survival. PLoS ONE. 9(11). e112930–e112930. 40 indexed citations
17.
18.
Xu, Yumin, Hui Wang, Fazal H. Tabassam, et al.. (2013). Amelioration of Liver Injury by Continuously Targeted Intervention against TNFRp55 in Rats with Acute-on-Chronic Liver Failure. PLoS ONE. 8(7). e68757–e68757. 17 indexed citations
19.
Zhao, Gangde, Baoyan An, Huijuan Zhou, et al.. (2012). Impairment of the retinoic acid-inducible gene-I-IFN-β signaling pathway in chronic hepatitis B virus infection. International Journal of Molecular Medicine. 30(6). 1498–1504. 9 indexed citations
20.
Yang-de, Zhang & Yumin Xu. (2001). Viability and histological changes of encapsulated rat hepatocyte after transplantation. 22(3). 161–163. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jin‐Zhong Dong Breakdown of academic impact, for papers by Sanae Hayashi Breakdown of academic impact, for papers by María Mora González López Ledesma Breakdown of academic impact, for papers by Hongshan Wei Breakdown of academic impact, for papers by John T. Baber Breakdown of academic impact, for papers by Hye–Jun Shin Breakdown of academic impact, for papers by Reben Raeman Breakdown of academic impact, for papers by Shanthi Wasser Breakdown of academic impact, for papers by Huichun Xing Breakdown of academic impact, for papers by Lingling Jia
Rankless by CCL
2026